ATE207357T1 - Verwendung von cotinin zur linderung des tabakentzugssyndrom - Google Patents

Verwendung von cotinin zur linderung des tabakentzugssyndrom

Info

Publication number
ATE207357T1
ATE207357T1 AT93911342T AT93911342T ATE207357T1 AT E207357 T1 ATE207357 T1 AT E207357T1 AT 93911342 T AT93911342 T AT 93911342T AT 93911342 T AT93911342 T AT 93911342T AT E207357 T1 ATE207357 T1 AT E207357T1
Authority
AT
Austria
Prior art keywords
cotinine
withdrawal syndrome
tobacco withdrawal
relief
tobacco
Prior art date
Application number
AT93911342T
Other languages
English (en)
Inventor
Robert M Keenan
Dorothy K Hatsukami
Original Assignee
Pharmaco Behavioral Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/885,314 external-priority patent/US5596007A/en
Priority claimed from US07/964,277 external-priority patent/US5643928A/en
Application filed by Pharmaco Behavioral Ass filed Critical Pharmaco Behavioral Ass
Application granted granted Critical
Publication of ATE207357T1 publication Critical patent/ATE207357T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AT93911342T 1992-05-18 1993-05-17 Verwendung von cotinin zur linderung des tabakentzugssyndrom ATE207357T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/885,314 US5596007A (en) 1992-05-18 1992-05-18 Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US07/964,277 US5643928A (en) 1992-10-21 1992-10-21 Human body weight management
PCT/US1993/004672 WO1993023045A1 (en) 1992-05-18 1993-05-17 Use of cotinine to alleviate tobacco withdrawal syndrome

Publications (1)

Publication Number Publication Date
ATE207357T1 true ATE207357T1 (de) 2001-11-15

Family

ID=27128757

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911342T ATE207357T1 (de) 1992-05-18 1993-05-17 Verwendung von cotinin zur linderung des tabakentzugssyndrom

Country Status (9)

Country Link
EP (1) EP0641206B1 (de)
JP (1) JPH07508036A (de)
AT (1) ATE207357T1 (de)
AU (1) AU670794B2 (de)
CA (1) CA2136019A1 (de)
DE (1) DE69331008T2 (de)
FI (1) FI945446L (de)
NZ (1) NZ252618A (de)
WO (1) WO1993023045A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643928A (en) * 1992-10-21 1997-07-01 Pharmaco Behavioral Associates, Inc. Human body weight management
WO1995029676A1 (en) * 1994-04-29 1995-11-09 Pharmaco Behavioral Associates, Inc. Human body weight management
WO1996027303A1 (en) * 1995-03-06 1996-09-12 Lectec Corporation Nicotine-free smoking material
WO1996029076A2 (en) * 1995-03-17 1996-09-26 Lectec Corporation Treatment of inflammatory bowel disorders with cotinine
KR100352030B1 (en) * 2002-01-10 2002-09-11 Orion Corp Gum composition for removing nicotine
EP2086541A4 (de) * 2006-10-09 2011-06-22 Glaxosmithkline Llc Zusammensetzungen zur reduzierung von nikotinentzugssymptomen und/oder tabakverbrauch
CL2008003507A1 (es) * 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428M (fr) * 1962-08-06 1964-03-31 Medical College Of Virginia Fo Antispasmodique.
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds

Also Published As

Publication number Publication date
FI945446A0 (fi) 1994-11-18
DE69331008T2 (de) 2002-07-18
JPH07508036A (ja) 1995-09-07
CA2136019A1 (en) 1993-11-25
DE69331008D1 (de) 2001-11-29
FI945446A7 (fi) 1995-01-18
AU4251293A (en) 1993-12-13
FI945446L (fi) 1995-01-18
NZ252618A (en) 1996-04-26
EP0641206A1 (de) 1995-03-08
EP0641206B1 (de) 2001-10-24
AU670794B2 (en) 1996-08-01
WO1993023045A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
DE69110785D1 (de) Narkosemittelverdampfer.
DE59107331D1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
NO884124L (no) Kapasitivt maaleapparat for tomroms-andel.
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DE3777805D1 (de) Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
FI924711A7 (fi) Kevytsavukesuodatin ja savukkeita varustettuina ko. suodattimella
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
DE69104875D1 (de) Verminderung des Chloridgehaltes in Polysiloxanen.
DK0583026T3 (de)
GR3034757T3 (en) Compositons for the treatment of chronic fatigue syndrome.
EP0338415A3 (de) Verwendung von Sulfonylharnstoff-Derivaten bei der Behandlung von Ödemen
MD1716C2 (ro) Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
IT1224250B (it) Associzione del depiprazolo con la morfina
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
ES2101000T3 (es) Uso de bmy 14802 en el tratamiento de la ansiedad en pacientes con sindrome de abstinencia de benzodiazepinas.
ATE73999T1 (de) Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties